Suvretta Capital Management »

Hims & Hers Heal shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Hims & Hers Heal (HIMS) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Hims & Hers Heal

Tip: Access up to 7 years of quarterly data

All positions including Hims & Hers Heal held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hims & Hers Heal by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $83M 2.6M 32.47

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcutis Biotherapeutics (ARQT)
Ark Etf Tr Genomic Rev Etf Put Option (ARKG)
Benitec Biopharma Com New (BNTC)
Legend Biotech Corp Sponsored Ads (LEGN)
Eyepoint Com New (EYPT)
Arcus Biosciences Incorporated (RCUS)
Immatics SHS (IMTX)
Biohaven (BHVN)
Meta Platforms Cl A (META)
Apellis Pharmaceuticals (APLS)
NVIDIA Corporation (NVDA)
Coca-Cola Company (KO)
Ge Aerospace Com New (GE)
Amazon (AMZN)

View all positions for Suvretta Capital Management

Top funds holding Hims & Hers Heal

BlackRock
Vanguard Group
Jpmorgan Chase & Co
Susquehanna International
Capital World Investors
Citadel Advisors
Goldman Sachs Group
Jane Street
State Street Corporation
Geode Capital Management
Renaissance Technologies
UBS Group
D. E. Shaw & Co
Farallon Capital Management
Squarepoint Ops

View all funds holding Hims & Hers Heal